Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina.
To elucidate the circadian variation of fibrinolytic components in vasospastic angina, plasma levels of tissue plasminogen activator antigen (t-PA), free plasminogen activator inhibitor antigen (free PAI-1), t-PA/PAI-1 complex, and total PAI-1 were measured in venous plasma samples. Samples were taken every 6 hours (6:00 AM, noon, 6:00 PM, and midnight) for 24 hours in 14 patients with vasospastic angina, in 9 patients with exertional angina, and in 19 normal subjects. Twenty-four-hour Holter monitoring (Holter monitor, Del Mar Avionics, Irvine, Calif.) was also carried out in all subjects. All of the fibrinolytic components showed circadian variation, with a peak level at 6:00 AM in every study group except for the t-PA/PAI-1 complex in the group of patients with exertional angina. The values for all or the fibrinolytic components at each sampling time were higher in patients with coronary artery disease than in normal subjects. In particular, the mean value of free PAI-1 at 6:00 AM in patients with vasospastic angina was significantly higher than that in normal subjects and that in patients with exertional angina. This value of free PAI-1 in patients with vasospastic angina was closely associated with the duration of ischemic attacks. These results suggested that the circadian fluctuation of fibrinolytic components may be an important factor that leads to coronary thrombosis at the time of coronary spasm, especially in the early morning.
Sakata
K
K
Department of Cardiology, Shizuoka General Hospital, Japan.
Hoshino
T
T
Yoshida
H
H
Ono
N
N
Ohtani
S
S
Yokoyama
S
S
Mori
N
N
Kaburagi
T
T
Kurata
C
C
Urano
T
T
D000109:Acetylcholine; D000787:Angina Pectoris / Q000097:blood / Q000175:diagnosis; D000788:Angina Pectoris, Variant / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D006328:Cardiac Catheterization; D002940:Circadian Rhythm / Q000502:physiology*; D003328:Coronary Thrombosis / Q000209:etiology; D015716:Electrocardiography, Ambulatory; D005080:Exercise Test; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D015849:Plasminogen Inactivators / Q000378:metabolism*; D011877:Radionuclide Imaging; D010959:Tissue Plasminogen Activator / Q000378:metabolism*
D015849:Plasminogen Inactivators; D010959:Tissue Plasminogen Activator; D000109:Acetylcholine